MARATTO

article · Lung Cancer

Diagnostic and therapeutic approach of rare thoracic tumors

Abstract

<b>Introduction:</b> Rare primary thoracic tumors are defined as tumors of unusual histopathology developped in the thorax. They represent less than 1% of primary lung tumors. <b>Materials and Methods:</b> Study during 5 years (2015-2020) including patients with thoracic mass. <b>Results:</b> Twenty patients (12 men and 8 women). Diagnostic means were per-endoscopic in 6 cases, the scano-guided needle biopsy in 10 cases, and surgical in 4 cases. Histological types were: carcinoid tumor (n=6), large cell sarcomatoid carcinoma (n=1), pleomorphic carcinoma (n=2), pulmonary blastoma (n=3), basaloid carcinoma (n=1), primary lymphoma of the lung (n=1), thymic carcinoma with angiomatoid component (n = 1), pulmonary artery sarcoma (n=2),primary pulmonary sarcoma (n=1), Giant cell bone tumor (n=1) and Schwannoma (n=1). <b>Conclusion:</b> The control of the progression of a tumor is based on a reasoned diagnostic approach and the early implementation of an appropriate treatment. The progress made in medical imaging, associated with the work of clinicians and pathologists, now allows increasingly early diagnosis for better management of rare intrathoracic tumors.

Research topics

  • Congenital Diaphragmatic Hernia Studies
  • Soft tissue tumor case studies
  • Sarcoma Diagnosis and Treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1183/13993003.congress-2023.pa5152

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.